Cancer Prevention Pharmaceuticals' Convertible Note Round

Cancer Prevention Pharmaceuticals raised a round of funding on January 22, 2016.

Cancer Prevention Pharmaceuticals (CPP) develops therapies to prevent cancers in people with elevated risk for these diseases. The company is initially focused on colon cancer; however, CPP also has t…

Articles about Cancer Prevention Pharmaceuticals' Convertible Note Round: